Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market, Price & Analysis > Featured News - Ofloxacin > Prologue Pharmaceuticals invests in the establishment of a CDMO R&D center in the United States to further enhance the competitiveness of the CDMO market
— Share —

Prologue Pharmaceuticals invests in the establishment of a CDMO R&D center in the United States to further enhance the competitiveness of the CDMO market

healthoo 2021-08-27
In order to further promote the "Strong CDMO" strategy, expand overseas markets, and accelerate the strategic layout of international development

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.